The Consortium

In this consortium the top European research laboratories in the field of urological oncological research, particularly prostate cancer, have joined forces with strong disciplinary teams in the field of molecular life sciences.

The experimental urology laboratories have the advantage of covering the distance from the (unmet) clinical need to the experimental research approach and vice versa, i.e. research plans are aimed at clinical questions, in the case of this proposal the treatment of hormone unresponsive prostate cancer.





Participants



Short name Name Department
UMCN University Medical Centre Nijmegen Experimental Urology
EMC Erasmus Medical Centre Pathology & Urology
IGBMC INSERM/IGBMC Molecular Pathology / Structural Biology & Genomics
UOS University of Sheffield Urology
TURKU University of Turku Medical Biotechnology Department
Compound Handling Compound Handling B.V.
INN Innsbruck Medical University Urology
NEWC University of Newcastle Institute of Toxicology and Genetics
FZK Forschungszentrum Karlsruhe
BERN University of Bern Urology
YORK University of York Biology
CeRePP Centre de Recherche pour les Pathologies Prostatiques
LUMC Leiden University Medical Centre Endocrinology & Urology
TAMP University of Tampere Institute of Medical Technology
WIS Weizmann Institute of Science Molecular Cell Biology
UCAM University of Cambridge Surgery & Oncology